Shire

ShireShire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.

www.shire.com

Shire RSS Channel

Display # 
Title Published Date
One family's history of the rare condition Fabry disease through the generations 28 April 2016
Shire to combine with Baxalta, creating the global leader in rare diseases 14 January 2016
Shire partners with CrowdMed to offer US employees an innovative digital crowdsourcing diagnostic service 09 December 2015
Shire acquires Meritage Pharma 24 February 2015
Shire acquires Premacure AB 12 March 2013
Shire and Boston Children's Hospital enter into broad research collaboration 20 November 2012
Shire continued strong product sales performance in Q3 28 October 2011
Shire to establish new Regenerative Medicine business unit through cash acquisition of Advanced BioHealing, Inc. 18 May 2011
Shire delivers a strong first quarter performance 28 April 2011
Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse® 10 January 2011
Shire Expands Pipeline to Treat Orphan Muscle Diseases through Collaboration with Acceleron Pharma 10 September 2010
Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships 01 September 2010
Shire Proposes to Expand Specialist Gastrointestinal Portfolio 04 August 2010
Shire Purchases Strategic Site in Massachusetts 01 July 2010
VYVANSE® - new ADHD treatment option - now available in Canada 02 February 2010
FDA Determines VYVANSE® was Properly Granted Five-Year Market Exclusivity 26 October 2009
Shire Limited has changed its name to Shire plc 01 October 2008
Shire proposes acquisition of Jerini AG for an equity purchase price of €328 million 04 July 2008
Shire plc accelerating new product sales drive revenue growth of 36% 21 February 2008
Shire's ELAPRASE® (idursulfase) Approved in Japan For the Treatment of Hunter Syndrome 05 October 2007

Most Popular Now

One family's history of the rare co…

In recognition of International Fabry Awareness month, Shire has released the trailer for Our Fabry Family Tree, a short film series featuring a family who were unknowing...

Read more

What's the secret to living a full …

If you have ever asked yourself, "What makes me feel most fulfilled?" you are not alone. Nearly 2 million people recently answered that question in a new survey by Abbott...

Read more

Bristol-Myers Squibb reports first …

Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the first quarter of 2016, which were highlighted by strong sales for Opdivo, Eliquis and our hepatitis...

Read more

Researchers discover potential trea…

Researchers at the Icahn School of Medicine at Mount Sinai say that tiny doses of a cancer drug may stop the raging, uncontrollable immune response to infection that lead...

Read more

Ready. Raise. Rise. Campaign

The Ready. Raise. Rise. campaign encourages everyone to raise and share a flag to salute those who have been touched by cancer, especially patients and caregivers, and le...

Read more

Pfizer reports first-quarter 2016 r…

Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2016 and updated certain components of its 2016 financial guidance. Reported revenues totaled $13.0 b...

Read more

Research points to a new treatment …

Researchers have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis, pointing to a potential new treatment using drugs previously ...

Read more

'Mediterranean' diet linked to lowe…

A "Mediterranean" diet, high in fruit, vegetables, fish and unrefined foods, is linked to a lower risk of heart attack and stroke in people who already have heart disease...

Read more

AstraZeneca completes acquisition o…

AstraZeneca has completed the acquisition of the core respiratory business of Takeda Pharmaceutical Company Limited ("Takeda"). The agreement, announced in December 2015...

Read more

Why are women less likely to be pre…

Statins are equally effective at decreasing risk of coronary events in men and women, and yet women are less likely to be prescribed these cholesterol-lowering drugs than...

Read more

Grants4Apps Accelerator 2016: You i…

The Grants4Apps (G4A) Accelerator developed by Bayer invites health IT and technology startups to apply for the program's 2016 edition. This year, Bayer looks primarily i...

Read more

A faster and cheaper way to produce…

A novel way of synthesising a promising new antibiotic has been identified by scientists at the University of Bristol. By expressing the genes involved in the production ...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]